TipRanks
Go Ultimate55% OFF

US Stem Cell (USRM) Revenue

US Stem Cell Revenue

US Stem Cell had a revenue of 19.97K in the quarter ending Dec 31, 2022, with 40.20%. This bring the company's revenue in the last twelve months to 82.05K, Decreased 4.22%. In the fiscal year ending Dec 31, 2022, US Stem Cell had annual revenue of 82.05K with -59.13% growth.

Revenue (ttm)
82.05K
Revenue Growth
―
P/S Ratio
0.78
Revenue/Employee
$7,459
Employees
11
Market Cap
$64.15K

Revenue Chart

US Stem Cell Revenue - Annual

02M4M6M8M5.52M6.70M3.07M277.09K200.75K82.05K201720182019202020212022
Revenue History
Download to Excel
USRM revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202282.05K-118.70K-59.13%
Dec 31, 2021200.75K-76.34K-27.55%
Dec 31, 2020277.09K-2.80M-90.98%
Dec 31, 20193.07M-3.63M-54.15%
Dec 31, 20186.70M1.18M21.38%
Dec 31, 20175.52M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
USRM82.05K
MBIO0.00
BRTX357.87K
BCDA0.00
BBLG0.00
CELZ3.00K